In a report published by 'El Global' BioSim exposes the opportunities for improvement of Profarma, the framework of actions to promote the competitiveness of the pharmaceutical industry.
The dawn of the next (Profarma 2021-2024) have coincided with the most momentous year for the health and pharmaceutical sector globally. The coronavirus crisis places Profarma, perhaps, before one of the biggest changes in its history.
